✦ LIBER ✦

Strong natural killer (NK) cell activity in bone marrow of myeloma patients: Accelerated maturation of bone marrow NK cells and their interaction with other bone marrow cells

✍ Scribed by Atsushi Uchida; Masato Yagita; Hiroyuki Sugiyama; Takashi Hoshino; Michael Moore

Publisher: John Wiley and Sons
Year: 1984
Tongue: French
Weight: 760 KB
Volume: 34
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.2910340314

No coin nor oath required. For personal study only.

✦ Synopsis

Bone marrow natural killer (NK) cell activity was lopoiesis and possibly in vivo hematopoiesis (Hansson studied in patients with multiple myeloma. Bone marrow et a[., 1982; Lotzo\ra et al,, 1979). mononuclear cells from myeloma patients expressed consjde.b levels of cytotoxicity K562 i n a , , s~=, .

📜 SIMILAR VOLUMES

Tumor-primed natural killer cells from p

Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells

✍ Eirini Katodritou; Evangelos Terpos; Janet North; Panagiotis Kottaridis; Evgenia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

## Abstract Natural killer (NK) cells are cytotoxic lymphocytes able to kill tumor cells and virus‐infected cells. Human‐resting NK cells can be activated by co‐culture with NK‐resistant CTV‐1a cells. These tumor‐activated cells (TaNKs) are cytotoxic to a range of NK‐resistant tumor cells in vitro.

Generation of mouse natural killer (NK)

Generation of mouse natural killer (NK) cell activity: Effect of interleukin-2 (IL-2) and interferon (IFN) on the in vivo development of natural killer cells from bone marrow (BM) progenitor cells

✍ Carlo Riccardi; Antonio Giampietri; Graziella Migliorati; Lorenza Cannarile; Luc 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 French ⚖ 956 KB

The possible effect of IL-2, a,P-IFN and poly I:C (an IFN inducer) administration on the generation of NK cells of LI and BM-reconstituted animals was investigated. B6D2FI mice were LI (9.5 Gy) by total-body irradiation and reconstituted by i.v. injection of different doses (ranging from lo6 to 2 x

Analysis of the activating receptors and

Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation

✍ Chiara Vitale; Laura Chiossone; Giuseppe Morreale; Edoardo Lanino; Francesca Cot 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 2 views

Bone marrow of patients with active mult

Bone marrow of patients with active multiple myeloma: Angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44

✍ Angelo Vacca; Michela Di Loreto; Domenico Ribatti; Rita Di Stefano; Gennaro Gada 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 908 KB

Induction of integrin β1 expression in b

Induction of integrin β1 expression in bone marrow cells after chemotherapy correlates with the overexpression of lung resistance protein and poor outcome in patients with multiple myeloma

✍ Morito Kurata; Yasunori Nakagawa; Kouhei Yamamoto; Kenshi Suzuki; Masanobu Kitag 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 1 views

Decrease in clonogenic tumour cells in b

Decrease in clonogenic tumour cells in bone marrow aspirates from multiple myeloma patients due to the incorporation of cyclophosphamide into treatment with vincristine, adriamycin and methyl prednisolone

✍ Dr. J. B. G. Bell; B. C. Millar; A. Montes-Borinaga; J. K. Joffe; D. Cunningham; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

A study of 32 patients receiving cyclophosphamide (CY) and verapamil (VER) in addition to the drug combination vincristine, adriamycin and methyl prednisolone (VAMP) was made in which the clinical response and growth of clonogenic myeloma cells (MY-CFUJ from bone marrow aspirates were compared. At p